Ariadne (psychedelic): Difference between revisions
Jump to navigation
Jump to search
m Protected "Ariadne (psychedelic)": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}) |
||
| Line 21: | Line 21: | ||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
== See also == | == See also == | ||
Latest revision as of 14:28, 4 September 2012
| Ariadne | |
|---|---|
| Chemical name | 4-methyl-2,5-dimethoxy-alpha-ethylphenethylamine or 2-(4-methyl-2,5-dimethoxyphenyl)ethan-alpha-ethylamine |
| Chemical formula | C13H21NO2 |
| Molecular mass | 209.284 g/mol |
| SMILES | COc1cc(C)c(cc1CC(C)N)OC |
| File:Ariadne (psychedelic).png File:Ariadne-3d-sticks.png | |
.png){kind=link}
Ariadne, or 4-methyl-2,5-dimethoxy-alpha-ethylphenethylamine, is a lesser-known psychedelic drug. It is an analog of 2C-D. Ariadne was first synthesized by Alexander Shulgin. In his book PIHKAL (Phenethylamines I Have Known and Loved), the dosage and duration are both unknown. Ariadne produces psychedelia and a bare threshold.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of Ariadne.